IPATF - IPATF Stock Soars: Subsidiary Receives Exclusive License from Standford

On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF stock soared, up nearly 15% at the time of writing on the OTC market.

Here’s what we know.

U-Protein Express is a wholly-owned subsidiary of ImmunoPrecise Antibodies (TSXV:IPA) (OTCQB:IPATF), which is a therapeutic antibody discovery company based in Victoria, British Columbia, Canada. Today, the subsidiary said Standford University has granted ...